- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Torrent Pharmaceuticals Ltd. (TORP)
Torrent Pharmaceuticals Ltd. stock price live, this page displays NSE TORP stock exchange data. View the TORP premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Torrent Pharmaceuticals Ltd. real time stock price chart below.
What Is the Torrent Pharmaceuticals Ltd. Stock Price Today?
The Torrent Pharmaceuticals Ltd. stock price today is 4,656.90.
What Is the Stock Symbol for Torrent Pharmaceuticals Ltd.?
The stock symbol for Torrent Pharmaceuticals Ltd. is "TORP."
What Stock Exchange Does Torrent Pharmaceuticals Ltd. Trade On?
Torrent Pharmaceuticals Ltd. is listed and trades on the NSE stock exchange.
Is Torrent Pharmaceuticals Ltd. a Good Stock to Buy?
Determining whether Torrent Pharmaceuticals Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TORP quote. (ISIN: INE685A01028)
What Is the Torrent Pharmaceuticals Ltd. Stock Price Today?
The Torrent Pharmaceuticals Ltd. stock price today is 4,656.90.
What Is the Stock Symbol for Torrent Pharmaceuticals Ltd.?
The stock symbol for Torrent Pharmaceuticals Ltd. is "TORP."
What Stock Exchange Does Torrent Pharmaceuticals Ltd. Trade On?
Torrent Pharmaceuticals Ltd. is listed and trades on the NSE stock exchange.
Is Torrent Pharmaceuticals Ltd. a Good Stock to Buy?
Determining whether Torrent Pharmaceuticals Ltd.—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the TORP quote. (ISIN: INE685A01028)
Currency in INR
4,656.90
+39.80(+0.86%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,590.00
4,660.00
52 wk Range
3,480.60
5,250.00
Earnings results expected in 11 days
1/2
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
4,590.004,660.00
52 wk Range
3,480.605,250.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.94%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(0.94%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
TORNTPHARM Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts anticipate sales growth in the current year
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Torrent Pharmaceuticals Ltd. Earnings Call Summary for Q1/2027
- Q1 FY2027 revenue surged 55% YoY to INR 4,921 crores; operating EBITDA jumped 61% to INR 1,664 crores with 33.8% margin.
- JB Pharma merger completed six months early; cost synergies exceed INR 100 crore target, ahead of original INR 90 crore plan.
- Semaglutide supply disruption to impact sales through August; alternate source secured with full SKU availability expected by month-end.
- Management withheld full-year combined guidance pending integration progress; expects U.S. profitability in FY2027, Brazil mid-teens growth in Q2.
- India branded business grew 19% vs. 12% market growth; stock flat at INR 4,872 as investors weigh strong results against cautious outlook.
Last Updated: 2026-07-30, 09:24 a/m
Read Full TranscriptEarnings
Latest Release
Jul 30, 2026
EPS / Forecast
15.40 / 15.04
Revenue / Forecast
49.21B / 47.23B
Compare TORNTPHARM to Peers and Sector
Metrics to compare | TORNTPHARM | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipTORNTPHARMPeersSector | |
|---|---|---|---|---|
P/E Ratio | 81.3x | 32.7x | −0.3x | |
PEG Ratio | 14.32 | 1.71 | 0.00 | |
Price/Book | 21.1x | 5.7x | 2.6x | |
Price / LTM Sales | 11.3x | 5.7x | 3.0x | |
Upside (Analyst Target) | 17.7% | 21.9% | 59.8% | |
Fair Value Upside | Unlock | 4.2% | 7.1% | Unlock |
Torrent Pharmaceuticals Limited engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, Malta, and internationally. The company offers products in various therapeutic areas, including anti-diabetic, anti-microbial, cardiovascular, CNS, urology, gynecology, oncology, gastro-intestinal, nephrology, neuro-psychiatric, dermatology, pulmonology, pediatric treatments, nutritional, pain management, anti-infective, and miscellaneous, as well as vitamins, minerals, and nutrients. It also provides contract manufacturing services. The company offers its products under Tedibar, Shelcal, Unienzyme, ProZuca, and Ahaglow brands. The company was formerly known as Trinity Laboratories and changed its name to Torrent Pharmaceuticals Limited in 1971. The company was founded in 1959 and is based in Ahmedabad, India. Torrent Pharmaceuticals Limited is a subsidiary of Torrent Investments Private Limited.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Torrent Pharmaceuticals (TORNTPHARM) Stock Price Today?
The Torrent Pharmaceuticals stock price today is 4,656.90 INR.
What Stock Exchange Does Torrent Pharmaceuticals Trade On?
Torrent Pharmaceuticals is listed and trades on the India National Stock Exchange.
What Is the Stock Symbol for Torrent Pharmaceuticals?
The stock symbol for Torrent Pharmaceuticals is "TORNTPHARM."
Does Torrent Pharmaceuticals Pay Dividends? What’s The Current Dividend Yield?
The Torrent Pharmaceuticals dividend yield is 0.94%.
What Is the Torrent Pharmaceuticals Market Cap?
As of today, Torrent Pharmaceuticals market cap is 1.77T INR.
What Is Torrent Pharmaceuticals's Earnings Per Share (TTM)?
The Torrent Pharmaceuticals EPS (TTM) is 62.51.
When Is the Next Torrent Pharmaceuticals Earnings Date?
Torrent Pharmaceuticals will release its next earnings report on Oct 23, 2026.
From a Technical Analysis Perspective, Is TORNTPHARM a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Torrent Pharmaceuticals Stock Split?
Torrent Pharmaceuticals has split 3 times.
How Many Employees Does Torrent Pharmaceuticals Have?
Torrent Pharmaceuticals has 18258 employees.
What is the current trading status of Torrent Pharmaceuticals (TORNTPHARM)?
As of Oct 12, 2026, Torrent Pharmaceuticals (TORNTPHARM) is trading at a price of 4,656.90 INR, with a previous close of 4,656.90 INR. The stock has fluctuated within a day range of 4,590.00 INR to 4,660.00 INR, while its 52-week range spans from 3,480.60 INR to 5,250.00 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.